- Losers: View (VIEW) -62% reaches deal with Cantor Fitzgerald and RXR to become a private company.
- BYND Cannasoft Enterprises (BCAN) -28% announces financial results for the year ended December 31, 2023.
- Acorda Therapeutics (ACOR) -25%.
- HWH International (HWH) -23%.
- Enveric Biosciences (ENVB) -13%.
- Mesoblast Ltd (MESO) -10%.
- Emeren Group Ltd (SOL) -9%.
- Avalo Therapeutics (AVTX) -7%.
- Anghami (ANGH) -6%.
- Petros Pharmaceuticals (PTPI) -6%.
- Spectral AI (MDAI) -5%.
More on Pre-market losers & stocks.
- Emeren Group Ltd. (SOL) Q4 2023 Earnings Call Transcript
- Mesoblast Limited (MESO) Q2 2024 Earnings Call Transcript
- Mesoblast Limited 2024 Q2 - Results - Earnings Call Presentation
- Acorda falls 59% as it files for Chapter 11 bankruptcy
- Emeren guides for growth in 2024 despite larger year-earlier loss